Pub Date : 2026-01-13eCollection Date: 2026-01-01DOI: 10.4103/tcmj.TCMJ-D-25-00004
Yao-Nan Wang, Ko-Tung Chang, Jui-Kai Liu, Chang-Hsien Tai
Cell culture technologies are fundamental tool in biological research. Traditional two-dimensional (2D) cell culture methods, despite their widespread use and simplicity, fail to accurately replicate the physiological conditions of native tissues, leading to altered cellular behavior. Recent advancements in 3D culture techniques, combined with innovative fabrication methods such as photolithography, paper-based, and 3D printing, have substantially improved the fidelity of cell culture models. In parallel, numerical simulations have become indispensable for optimizing the design and performance of these systems, offering precise control microenvironmental factors such as fluid dynamics, nutrient and oxygen gradients, and shear stress within microfluidic platforms. These approaches for integration facilitate accurate modeling of cell-to-cell and cell-to-matrix interactions essential for physiological relation. Concurrently, the integration of multimaterial fabrication techniques provides scalable and customizable solutions for developing sophisticated microfluidic and cell culture systems. This review discusses recent developments in these fabrication methods and highlights their integration with numerical simulation for optimization design, explores their collective potential to advance biomedical research and applications.
{"title":"Cell culture platform fabrication methods and applications.","authors":"Yao-Nan Wang, Ko-Tung Chang, Jui-Kai Liu, Chang-Hsien Tai","doi":"10.4103/tcmj.TCMJ-D-25-00004","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00004","url":null,"abstract":"<p><p>Cell culture technologies are fundamental tool in biological research. Traditional two-dimensional (2D) cell culture methods, despite their widespread use and simplicity, fail to accurately replicate the physiological conditions of native tissues, leading to altered cellular behavior. Recent advancements in 3D culture techniques, combined with innovative fabrication methods such as photolithography, paper-based, and 3D printing, have substantially improved the fidelity of cell culture models. In parallel, numerical simulations have become indispensable for optimizing the design and performance of these systems, offering precise control microenvironmental factors such as fluid dynamics, nutrient and oxygen gradients, and shear stress within microfluidic platforms. These approaches for integration facilitate accurate modeling of cell-to-cell and cell-to-matrix interactions essential for physiological relation. Concurrently, the integration of multimaterial fabrication techniques provides scalable and customizable solutions for developing sophisticated microfluidic and cell culture systems. This review discusses recent developments in these fabrication methods and highlights their integration with numerical simulation for optimization design, explores their collective potential to advance biomedical research and applications.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"21-30"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: The role of LOC441461, a long noncoding RNA, differs in different cancer types, and its role in lung cancer remains unclear.
Materials and methods: We investigated the clinical significance of LOC441461 expression in lung cancer using bioinformatics analyses. To explore the biological function of LOC441461, we performed siRNA-mediated knockdown in lung cancer cells and evaluated its effects on cell proliferation, colony formation, apoptosis, and cell cycle progression.
Results: LOC441461 was found to be significantly overexpressed in lung adenocarcinoma (LUAD), and LOC441461 overexpression was significantly associated with poor prognosis in patients with LUAD. LOC441461 knockdown significantly inhibited cell growth and induced a modest but statistically significant increase in apoptosis in lung cancer cells. According to a cell cycle analysis, LOC441461 knockdown induced G0/G1 arrest in A549 cells; increased p21 and p27 expression; and reduced the levels of CDK4 and the cyclins A2, B1, and D1, similar to p53-dependent regulation. By contrast, H1299 cells exhibited G2/M accumulation with no change in p21 and p27 levels, suggesting a p53-independent mechanism.
Conclusion: Our findings indicate that high LOC441461 expression is correlated with worse prognosis in LUAD. These results support the potential of LOC441461 as a novel therapeutic and prognostic target in LUAD.
{"title":"Long noncoding RNA LOC441461 drives cancer growth and is associated with poor clinical outcomes.","authors":"Ching-Feng Cheng, Ya-Ting Tu, Yi-Ru Chen, Ming-Cheng Lee, Hui-Chen Ku, Kuo-Wang Tsai","doi":"10.4103/tcmj.TCMJ-D-25-00032","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00032","url":null,"abstract":"<p><strong>Objectives: </strong>The role of LOC441461, a long noncoding RNA, differs in different cancer types, and its role in lung cancer remains unclear.</p><p><strong>Materials and methods: </strong>We investigated the clinical significance of LOC441461 expression in lung cancer using bioinformatics analyses. To explore the biological function of LOC441461, we performed siRNA-mediated knockdown in lung cancer cells and evaluated its effects on cell proliferation, colony formation, apoptosis, and cell cycle progression.</p><p><strong>Results: </strong>LOC441461 was found to be significantly overexpressed in lung adenocarcinoma (LUAD), and LOC441461 overexpression was significantly associated with poor prognosis in patients with LUAD. LOC441461 knockdown significantly inhibited cell growth and induced a modest but statistically significant increase in apoptosis in lung cancer cells. According to a cell cycle analysis, LOC441461 knockdown induced G0/G1 arrest in A549 cells; increased p21 and p27 expression; and reduced the levels of CDK4 and the cyclins A2, B1, and D1, similar to p53-dependent regulation. By contrast, H1299 cells exhibited G2/M accumulation with no change in p21 and p27 levels<b>,</b> suggesting a p53-independent mechanism.</p><p><strong>Conclusion: </strong>Our findings indicate that high LOC441461 expression is correlated with worse prognosis in LUAD. These results support the potential of LOC441461 as a novel therapeutic and prognostic target in LUAD.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"75-82"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13eCollection Date: 2026-01-01DOI: 10.4103/tcmj.TCMJ-D-25-00041
Ya-Chu Wu, Pei-Chen Li, Dah-Ching Ding
Congenital anomalies of the female genital tract, such as vaginal septa, arise from disruptions in Müllerian ducts and urogenital sinus development. Vaginal septa, including longitudinal and transverse types, are rare and often remain undiagnosed due to asymptomatic presentation. However, they can lead to significant complications such as dyspareunia, infertility, and obstructed labor. This narrative review aims to provide a detailed overview of the clinical presentation, diagnosis, and management of vaginal septum, with a particular focus on the challenges encountered during pregnancy and labor. A systematic search of PubMed, Web of Science, Scopus, and Embase identified 34 relevant articles, including 16 case reports detailing labor outcomes in women with vaginal septum. The review highlights that timely diagnosis through pelvic examination and imaging, such as magnetic resonance imaging or ultrasound, can prevent labor complications. Management options range from conservative observation in asymptomatic cases to surgical resection, which can be performed intrapartum or before delivery to facilitate vaginal birth. The presence of associated anomalies, including uterine malformations and renal agenesis, underscores the need for thorough evaluation. Postoperative outcomes are generally favorable, though careful surgical planning is essential to avoid complications such as restenosis or infection. Clinicians should remain highly vigilant for women with unexplained infertility, menstrual abnormalities, or labor obstruction. Early identification and individualized management of vaginal septum can optimize obstetric outcomes and preserve reproductive function. Future research should aim to improve early detection methods, refine surgical techniques, and investigate the genetic and embryological basis of these rare anomalies.
女性生殖道的先天性异常,如阴道间隔,是由勒氏管和泌尿生殖道窦发育的中断引起的。阴道间隔,包括纵向和横向型,是罕见的,往往仍未确诊,由于无症状的表现。然而,它们会导致严重的并发症,如性交困难、不孕症和难产。这篇叙述性综述的目的是提供阴道间隔的临床表现,诊断和管理的详细概述,特别侧重于怀孕和分娩期间遇到的挑战。通过对PubMed、Web of Science、Scopus和Embase的系统搜索,我们发现了34篇相关文章,其中包括16篇详细介绍阴道间隔妇女分娩结果的病例报告。回顾强调,及时诊断盆腔检查和影像学,如磁共振成像或超声,可以预防分娩并发症。治疗方案包括对无症状病例的保守观察到手术切除,手术切除可在产时或分娩前进行,以促进阴道分娩。存在相关的异常,包括子宫畸形和肾脏发育不全,强调需要进行彻底的评估。术后结果通常是良好的,尽管仔细的手术计划是必要的,以避免并发症,如再狭窄或感染。临床医生应对不明原因不孕、月经异常或分娩梗阻的妇女保持高度警惕。阴道间隔的早期识别和个体化治疗可以优化产科结局,保护生殖功能。未来的研究应致力于改进早期检测方法,改进手术技术,并研究这些罕见异常的遗传和胚胎学基础。
{"title":"Vaginal septum in women: A review of diagnosis, management, and obstetric outcomes.","authors":"Ya-Chu Wu, Pei-Chen Li, Dah-Ching Ding","doi":"10.4103/tcmj.TCMJ-D-25-00041","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00041","url":null,"abstract":"<p><p>Congenital anomalies of the female genital tract, such as vaginal septa, arise from disruptions in Müllerian ducts and urogenital sinus development. Vaginal septa, including longitudinal and transverse types, are rare and often remain undiagnosed due to asymptomatic presentation. However, they can lead to significant complications such as dyspareunia, infertility, and obstructed labor. This narrative review aims to provide a detailed overview of the clinical presentation, diagnosis, and management of vaginal septum, with a particular focus on the challenges encountered during pregnancy and labor. A systematic search of PubMed, Web of Science, Scopus, and Embase identified 34 relevant articles, including 16 case reports detailing labor outcomes in women with vaginal septum. The review highlights that timely diagnosis through pelvic examination and imaging, such as magnetic resonance imaging or ultrasound, can prevent labor complications. Management options range from conservative observation in asymptomatic cases to surgical resection, which can be performed intrapartum or before delivery to facilitate vaginal birth. The presence of associated anomalies, including uterine malformations and renal agenesis, underscores the need for thorough evaluation. Postoperative outcomes are generally favorable, though careful surgical planning is essential to avoid complications such as restenosis or infection. Clinicians should remain highly vigilant for women with unexplained infertility, menstrual abnormalities, or labor obstruction. Early identification and individualized management of vaginal septum can optimize obstetric outcomes and preserve reproductive function. Future research should aim to improve early detection methods, refine surgical techniques, and investigate the genetic and embryological basis of these rare anomalies.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"40-47"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lateral flow immunoassay (LFIA) is a widely recognized point-of-care diagnostic platform for detecting various analytes. It must meet the criteria of REASSURED, but poor sensitivity and lack of precision in test results remain the main bottlenecks of LFIA. Therefore, signal enhancement methods, such as devices, nanoprobes, or detection modes, can improve this platform. In this paper, many representative studies from the past decade on LFIA sensing platforms will be discussed in detail.
{"title":"Development of an enhanced sensitivity method for lateral flow immunoassays: An overview of strategies.","authors":"Chung-An Chen, Chi-Hung Liu, Natalie Yi-Ju Ho, Sheng Liu, Tsung-Ting Tsai","doi":"10.4103/tcmj.TCMJ-D-25-00061","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00061","url":null,"abstract":"<p><p>Lateral flow immunoassay (LFIA) is a widely recognized point-of-care diagnostic platform for detecting various analytes. It must meet the criteria of REASSURED, but poor sensitivity and lack of precision in test results remain the main bottlenecks of LFIA. Therefore, signal enhancement methods, such as devices, nanoprobes, or detection modes, can improve this platform. In this paper, many representative studies from the past decade on LFIA sensing platforms will be discussed in detail.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"11-20"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13eCollection Date: 2026-01-01DOI: 10.4103/tcmj.tcmj_319_24
Purboyo Solek, Eka Nurfitri, Taufan Prasetya, Anggia Farrah Rizqiamuti, Indra Sahril, Burhan, Uni Gamayani, Kusnandi Rusmil, Irvan Afriandi, Lukman Ade Chandra, Kevin Gunawan
Autism spectrum disorder (ASD) is a group of diverse neurodevelopmental conditions characterized by deficits in social communication and interaction, as well as confined and repetitive patterns of behaviors, interests, or activities. Currently, there are no standardized techniques for predicting functional ability in children with ASD, which can lead to undetected clinical impairments and delayed targeted treatments. To address this issue, a scoping review was conducted following the preferred reporting items for systematic reviews and meta-analyses criteria. Twelve articles met the inclusion criteria for this review. This study summarized the potential tools and parameters that may benefit in predicting abilities used in the daily lives of children with ASD. The collected tools varied widely, including clinical questionnaires, physical symptoms, laboratory tests, and imaging studies. These tools provided descriptions of various functional abilities that are altered in ASD, offering insights into the diverse manifestations of the disorder and potential approaches for assessment and intervention.
{"title":"Predictors of functional ability in autism spectrum disorder: A scoping review.","authors":"Purboyo Solek, Eka Nurfitri, Taufan Prasetya, Anggia Farrah Rizqiamuti, Indra Sahril, Burhan, Uni Gamayani, Kusnandi Rusmil, Irvan Afriandi, Lukman Ade Chandra, Kevin Gunawan","doi":"10.4103/tcmj.tcmj_319_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_319_24","url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) is a group of diverse neurodevelopmental conditions characterized by deficits in social communication and interaction, as well as confined and repetitive patterns of behaviors, interests, or activities. Currently, there are no standardized techniques for predicting functional ability in children with ASD, which can lead to undetected clinical impairments and delayed targeted treatments. To address this issue, a scoping review was conducted following the preferred reporting items for systematic reviews and meta-analyses criteria. Twelve articles met the inclusion criteria for this review. This study summarized the potential tools and parameters that may benefit in predicting abilities used in the daily lives of children with ASD. The collected tools varied widely, including clinical questionnaires, physical symptoms, laboratory tests, and imaging studies. These tools provided descriptions of various functional abilities that are altered in ASD, offering insights into the diverse manifestations of the disorder and potential approaches for assessment and intervention.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"48-58"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objectives: </strong>During radiation therapy, clear and stable body-surface markers are essential for accurate patient positioning. Peer benchmarking across four Taiwanese tertiary centers (January 2023-Mar 2024) revealed marker detachment rates of 0.8%-10.7%, whereas our in-house audit documented 15%, underscoring a significant quality gap (unpublished institutional quality assurance data). Marker detachment or fading commonly occurs due to daily activities, hygiene routines, and patient-specific factors, adversely affecting treatment accuracy, prolonging treatment duration, and increasing patient anxiety and medical costs. This study aimed to reduce the rate of marker detachment in radiotherapy patients from the previous level of approximately 15% to below 5%, thereby decreasing repositioning time, treatment delays, patient anxiety, family inconvenience, and hospital resource expenditure.</p><p><strong>Materials and methods: </strong>This was a single-center pre-post comparative study conducted from January to June 2023. Two hundred cancer patients undergoing radiation therapy participated in this study. Patients were classified using an in-house-developed red-green light marking system based on body mass index (BMI >25 or ≤25), educational level (high school or below and above high school), and presence of a specific caregiver. Patients with higher risk (BMI >25, education level ≤ high school, and no specific caregiver) received weekly education sessions emphasizing marker maintenance, whereas lower-risk patients received sessions at the beginning, middle, and near the end of treatment. Interventions included personalized educational pamphlets, hypoallergenic adhesive patches, standardized marker pen replacements, and systematic tracking using the MOSAIQ® Radiation Oncology Management System (Elekta AB, Sweden). Data on marker detachment rates, repositioning times, and patient anxiety (Beck Anxiety Inventory) were collected before and after implementation. Statistical analyses, including paired <i>t</i>-tests, were conducted to assess the significance of observed changes.</p><p><strong>Results: </strong>After the implementation of interventions, marker repositioning incidents significantly decreased from 82 instances (average 102.5 min/month) to 7 instances (average 23.4 min/month) (<i>P</i> < 0.001). The marker detachment rate was effectively reduced from approximately 15% to 3.5%, achieving the targeted goal. In addition, patient anxiety scores significantly decreased from an average of 5 points to 3 points (<i>P</i> < 0.001), reflecting clinically meaningful improvement.</p><p><strong>Conclusion: </strong>The implementation of a structured nursing intervention program, featuring a red-green light marking system, personalized education, and systematic management, effectively decreased marker detachment rates, repositioning times, and patient anxiety. These improvements highlight the feasibility and effectiveness of integrating su
{"title":"Enhancing self-care implementation and reducing marker detachment rates in cancer radiotherapy patients through diverse nursing care strategies.","authors":"Huei-Fang Yang, Hsueh-Ya Tsai, Ying-Hsiang Chou, Yu-Chen Hsieh, Shao-Ti Li, Hsiao-Ju Huang, Ya-Fang Ke, Pei-Fang Tsai, Hsiu-Man Chan, Yueh-Chun Lee","doi":"10.4103/tcmj.tcmj_121_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_121_25","url":null,"abstract":"<p><strong>Objectives: </strong>During radiation therapy, clear and stable body-surface markers are essential for accurate patient positioning. Peer benchmarking across four Taiwanese tertiary centers (January 2023-Mar 2024) revealed marker detachment rates of 0.8%-10.7%, whereas our in-house audit documented 15%, underscoring a significant quality gap (unpublished institutional quality assurance data). Marker detachment or fading commonly occurs due to daily activities, hygiene routines, and patient-specific factors, adversely affecting treatment accuracy, prolonging treatment duration, and increasing patient anxiety and medical costs. This study aimed to reduce the rate of marker detachment in radiotherapy patients from the previous level of approximately 15% to below 5%, thereby decreasing repositioning time, treatment delays, patient anxiety, family inconvenience, and hospital resource expenditure.</p><p><strong>Materials and methods: </strong>This was a single-center pre-post comparative study conducted from January to June 2023. Two hundred cancer patients undergoing radiation therapy participated in this study. Patients were classified using an in-house-developed red-green light marking system based on body mass index (BMI >25 or ≤25), educational level (high school or below and above high school), and presence of a specific caregiver. Patients with higher risk (BMI >25, education level ≤ high school, and no specific caregiver) received weekly education sessions emphasizing marker maintenance, whereas lower-risk patients received sessions at the beginning, middle, and near the end of treatment. Interventions included personalized educational pamphlets, hypoallergenic adhesive patches, standardized marker pen replacements, and systematic tracking using the MOSAIQ® Radiation Oncology Management System (Elekta AB, Sweden). Data on marker detachment rates, repositioning times, and patient anxiety (Beck Anxiety Inventory) were collected before and after implementation. Statistical analyses, including paired <i>t</i>-tests, were conducted to assess the significance of observed changes.</p><p><strong>Results: </strong>After the implementation of interventions, marker repositioning incidents significantly decreased from 82 instances (average 102.5 min/month) to 7 instances (average 23.4 min/month) (<i>P</i> < 0.001). The marker detachment rate was effectively reduced from approximately 15% to 3.5%, achieving the targeted goal. In addition, patient anxiety scores significantly decreased from an average of 5 points to 3 points (<i>P</i> < 0.001), reflecting clinically meaningful improvement.</p><p><strong>Conclusion: </strong>The implementation of a structured nursing intervention program, featuring a red-green light marking system, personalized education, and systematic management, effectively decreased marker detachment rates, repositioning times, and patient anxiety. These improvements highlight the feasibility and effectiveness of integrating su","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"117-122"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-07eCollection Date: 2026-01-01DOI: 10.4103/tcmj.tcmj_56_25
Abdulameer Jasim Jawad Al-Gburi
Objectives: Proper catheter selection during right trans-radial coronary angiography reduces procedure duration, costs, and vascular complications. The correlation between aorta morphological parameters assessed through computed tomography (CT) and requirement for larger catheter size was investigated in this study.
Materials and methods: This observational study includes 206 patients who underwent right trans-radial coronary angiography and had already undergone coronary CT angiography at a recognized center from April 2023 to January 2025. Patients who completed angiography using a Judkins left (JL) 3.5 (Group 1) catheter were compared with patients who required catheter exchange with a JL 4 or larger (Group 2). Both groups had their CT images analyzed for four specific aortic morphological variables.
Results: A total of 167 patients formed Group 1, whereas 39 patients formed Group 2. The significant differences were detected in the maximal area and length of the ascending aorta among the four aortic CT variables. In multivariable logistic regression model, the strongest association with the need for JL4 or more catheter (Group 2) was found with the maximal area of the ascending aorta (odds ratio [OR] 31.82 [(95% confidence interval [CI]) 1.21-831.18], P < 0.001) followed by length of the ascending aorta (OR 29.97 [(95% CI) 1.06-845.08], P < 0.001). An ascending aorta maximal area cutoff value was 12.25 cm2 (SN 94.9%, SP 95.2%) with the derived diameter of 3.94 cm.
Conclusion: Maximum area (with derived diameter) and ascending aortic length were the good predictors for suitable catheter selection during right trans-radial invasive coronary angiography.
{"title":"Judkins left catheter size selection during right trans-radial coronary angiography using preprocedural coronary computed tomography angiography.","authors":"Abdulameer Jasim Jawad Al-Gburi","doi":"10.4103/tcmj.tcmj_56_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_56_25","url":null,"abstract":"<p><strong>Objectives: </strong>Proper catheter selection during right trans-radial coronary angiography reduces procedure duration, costs, and vascular complications. The correlation between aorta morphological parameters assessed through computed tomography (CT) and requirement for larger catheter size was investigated in this study.</p><p><strong>Materials and methods: </strong>This observational study includes 206 patients who underwent right trans-radial coronary angiography and had already undergone coronary CT angiography at a recognized center from April 2023 to January 2025. Patients who completed angiography using a Judkins left (JL) 3.5 (Group 1) catheter were compared with patients who required catheter exchange with a JL 4 or larger (Group 2). Both groups had their CT images analyzed for four specific aortic morphological variables.</p><p><strong>Results: </strong>A total of 167 patients formed Group 1, whereas 39 patients formed Group 2. The significant differences were detected in the maximal area and length of the ascending aorta among the four aortic CT variables. In multivariable logistic regression model, the strongest association with the need for JL4 or more catheter (Group 2) was found with the maximal area of the ascending aorta (odds ratio [OR] 31.82 [(95% confidence interval [CI]) 1.21-831.18], <i>P</i> < 0.001) followed by length of the ascending aorta (OR 29.97 [(95% CI) 1.06-845.08], <i>P</i> < 0.001). An ascending aorta maximal area cutoff value was 12.25 cm<sup>2</sup> (SN 94.9%, SP 95.2%) with the derived diameter of 3.94 cm.</p><p><strong>Conclusion: </strong>Maximum area (with derived diameter) and ascending aortic length were the good predictors for suitable catheter selection during right trans-radial invasive coronary angiography.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"104-109"},"PeriodicalIF":1.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hemorrhagic stroke, mainly caused by intracerebral hemorrhage (ICH), is a severe neurological condition with high mortality and lasting disability. ICH involves bleeding into the brain parenchyma, hematoma formation, and subsequent edema and tissue damage, triggering inflammatory and degenerative responses that worsen secondary brain injury (SBI). Microglia, the brain's resident immune cells, are key mediators in this process. Their ability to sense, engulf, and clear hematoma-derived debris is essential for controlling neuroinflammation and promoting tissue repair. Central to microglial phagocytosis is lysosomal function. Lysosomes contain hydrolases - proteases, glycosidases, lipases, and nucleases - that degrade proteins, lipids, carbohydrates, and nucleic acids. This coordinated degradation ensures effective recycling of phagocytosed materials and clearance of cellular debris after hemorrhage. However, lysosomal dysfunction impairs microglial clearance capacity, leading to persistent inflammation, aggravated neuronal damage, and poor neurological recovery after ICH. This review focuses on the interplay between microglial activation, lysosomal function, and phagocytosis in hemorrhagic stroke. We examine how lysosomal impairment hinders hematoma resolution, propagates SBI, and delays functional recovery. In addition, we highlight emerging therapeutic strategies targeting the microglia-lysosome axis, such as enhancing lysosomal biogenesis and enzyme activity, as promising approaches to boost hematoma clearance and improve outcomes. Understanding and modulating microglial lysosomal function offers novel therapeutic avenues for ICH management, aiming to mitigate secondary injury and support neurological recovery.
{"title":"Microglial activation and lysosomal dysfunction in hemorrhagic stroke.","authors":"Chien-Hui Lee, Cheng-Yoong Pang, Mei-Jen Wang, Wei-Fen Hu, Hsin-Yi Huang, Sheng-Tzung Tsai, Hock-Kean Liew","doi":"10.4103/tcmj.tcmj_213_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_213_25","url":null,"abstract":"<p><p>Hemorrhagic stroke, mainly caused by intracerebral hemorrhage (ICH), is a severe neurological condition with high mortality and lasting disability. ICH involves bleeding into the brain parenchyma, hematoma formation, and subsequent edema and tissue damage, triggering inflammatory and degenerative responses that worsen secondary brain injury (SBI). Microglia, the brain's resident immune cells, are key mediators in this process. Their ability to sense, engulf, and clear hematoma-derived debris is essential for controlling neuroinflammation and promoting tissue repair. Central to microglial phagocytosis is lysosomal function. Lysosomes contain hydrolases - proteases, glycosidases, lipases, and nucleases - that degrade proteins, lipids, carbohydrates, and nucleic acids. This coordinated degradation ensures effective recycling of phagocytosed materials and clearance of cellular debris after hemorrhage. However, lysosomal dysfunction impairs microglial clearance capacity, leading to persistent inflammation, aggravated neuronal damage, and poor neurological recovery after ICH. This review focuses on the interplay between microglial activation, lysosomal function, and phagocytosis in hemorrhagic stroke. We examine how lysosomal impairment hinders hematoma resolution, propagates SBI, and delays functional recovery. In addition, we highlight emerging therapeutic strategies targeting the microglia-lysosome axis, such as enhancing lysosomal biogenesis and enzyme activity, as promising approaches to boost hematoma clearance and improve outcomes. Understanding and modulating microglial lysosomal function offers novel therapeutic avenues for ICH management, aiming to mitigate secondary injury and support neurological recovery.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"1-10"},"PeriodicalIF":1.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
End-stage kidney disease (ESKD) presents a major clinical burden, with maintenance hemodialysis (HD) patients facing high cardiovascular mortality and impaired quality of life (QoL). Despite advances from low-flux to high-flux HD and the introduction of hemodiafiltration (HDF), clearance of large middle molecules (LMMs >25 kDa) remains inadequate. These molecules contribute to inflammation, oxidative stress, atherogenesis, and mineral-bone disorders, all of which worsen patient outcomes. Expanded hemodialysis (HDx), utilizing medium cutoff membranes, represents a novel approach that combines diffusion and enhanced internal convection to improve LMMs removal, without the need for substitution fluid. This review explores the limitations of conventional HD, the pathological roles of LMMs, and the evolution of dialysis strategies aimed at enhancing solute clearance. Evidence from observational studies, randomized trials, and meta-analyses shows that HDx improves the removal of inflammatory LMMs, reduces hospitalization burden, preserves residual kidney function, and enhances patient-reported outcomes such as recovery time and symptom relief. Furthermore, HDx offers a practical and cost-effective alternative to online HDF (OL-HDF), particularly in the resource-limited settings, achieving comparable efficacy with shorter sessions and lower blood flow requirements. By addressing the key shortcomings of traditional HD and approaching the solute clearance profile of the native kidney, HDx offers a promising advancement in the care of ESKD patients.
{"title":"Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.","authors":"Chiu-Huang Kuo, Yu-Li Lin, Chi-Chong Tang, Bang-Gee Hsu","doi":"10.4103/tcmj.tcmj_192_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_192_25","url":null,"abstract":"<p><p>End-stage kidney disease (ESKD) presents a major clinical burden, with maintenance hemodialysis (HD) patients facing high cardiovascular mortality and impaired quality of life (QoL). Despite advances from low-flux to high-flux HD and the introduction of hemodiafiltration (HDF), clearance of large middle molecules (LMMs >25 kDa) remains inadequate. These molecules contribute to inflammation, oxidative stress, atherogenesis, and mineral-bone disorders, all of which worsen patient outcomes. Expanded hemodialysis (HDx), utilizing medium cutoff membranes, represents a novel approach that combines diffusion and enhanced internal convection to improve LMMs removal, without the need for substitution fluid. This review explores the limitations of conventional HD, the pathological roles of LMMs, and the evolution of dialysis strategies aimed at enhancing solute clearance. Evidence from observational studies, randomized trials, and meta-analyses shows that HDx improves the removal of inflammatory LMMs, reduces hospitalization burden, preserves residual kidney function, and enhances patient-reported outcomes such as recovery time and symptom relief. Furthermore, HDx offers a practical and cost-effective alternative to online HDF (OL-HDF), particularly in the resource-limited settings, achieving comparable efficacy with shorter sessions and lower blood flow requirements. By addressing the key shortcomings of traditional HD and approaching the solute clearance profile of the native kidney, HDx offers a promising advancement in the care of ESKD patients.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"31-39"},"PeriodicalIF":1.6,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral squamous cell carcinoma represents a significant public health challenge in Asia, where multimodal therapies, while extending survival, impose substantial biologic and psychosocial stress. Sustained activation of the sympathetic-adrenal-medullary axis and dysregulation of the hypothalamic-pituitary-adrenal axis increase catecholamines, cortisol, interleukin-6, and C-reactive protein, accelerating tumor progression, impairing treatment tolerance, and increasing cardiovascular risk. Betel quid chewing, prevalent in the region, exacerbates inflammation and contributes to cardiovascular comorbidities. Resilience, defined as the ability to restore physiologic and emotional homeostasis, modulates these pathways, with higher resilience linked to improved recovery, quality of life, and survival. Current evidence supports interventions including structured psychoeducation, cognitive-behavioral therapy, and peer mentoring to reduce anxiety and enhance treatment adherence. Smoking and betel quid cessation, alongside cardiometabolic optimization, mitigate inflammatory burden. Nonopioid strategies, including acupuncture, transcutaneous vagus nerve stimulation, and mindfulness, recalibrate neuro-immune signaling while minimizing opioid reliance. Enhanced recovery surgical protocols and omega-3 supplementation attenuate inflammatory responses and preserve lean mass. Emerging biomarkers such as heart rate variability and neutrophil-lymphocyte ratio show promise for real-time stress and inflammation monitoring. Digital health technologies and telerehabilitation extend intervention benefits postdischarge. Future research should focus on validating predictive biomarkers, developing resilience-stratified trials, integrating cardio-oncology surveillance, and implementing precision supportive care models that incorporate stress, inflammation, and resilience metrics to optimize oncologic and cardiovascular outcomes in this high-risk population.
{"title":"Stress, inflammation, and resilience among patients with oral squamous cell carcinoma undergoing multimodal therapy: Current knowledge and future directions.","authors":"Tai-Chu Peng, Chun-Hou Huang, Yu-Fu Chou, Peir-Rong Chen","doi":"10.4103/tcmj.tcmj_208_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_208_25","url":null,"abstract":"<p><p>Oral squamous cell carcinoma represents a significant public health challenge in Asia, where multimodal therapies, while extending survival, impose substantial biologic and psychosocial stress. Sustained activation of the sympathetic-adrenal-medullary axis and dysregulation of the hypothalamic-pituitary-adrenal axis increase catecholamines, cortisol, interleukin-6, and C-reactive protein, accelerating tumor progression, impairing treatment tolerance, and increasing cardiovascular risk. Betel quid chewing, prevalent in the region, exacerbates inflammation and contributes to cardiovascular comorbidities. Resilience, defined as the ability to restore physiologic and emotional homeostasis, modulates these pathways, with higher resilience linked to improved recovery, quality of life, and survival. Current evidence supports interventions including structured psychoeducation, cognitive-behavioral therapy, and peer mentoring to reduce anxiety and enhance treatment adherence. Smoking and betel quid cessation, alongside cardiometabolic optimization, mitigate inflammatory burden. Nonopioid strategies, including acupuncture, transcutaneous vagus nerve stimulation, and mindfulness, recalibrate neuro-immune signaling while minimizing opioid reliance. Enhanced recovery surgical protocols and omega-3 supplementation attenuate inflammatory responses and preserve lean mass. Emerging biomarkers such as heart rate variability and neutrophil-lymphocyte ratio show promise for real-time stress and inflammation monitoring. Digital health technologies and telerehabilitation extend intervention benefits postdischarge. Future research should focus on validating predictive biomarkers, developing resilience-stratified trials, integrating cardio-oncology surveillance, and implementing precision supportive care models that incorporate stress, inflammation, and resilience metrics to optimize oncologic and cardiovascular outcomes in this high-risk population.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"59-67"},"PeriodicalIF":1.6,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}